Literature DB >> 11904438

G protein-coupled receptor kinase 4 gene variants in human essential hypertension.

Robin A Felder1, Hironobu Sanada, Jing Xu, Pei-Ying Yu, Zheng Wang, Hidetsuna Watanabe, Laureano D Asico, Wei Wang, Shaopeng Zheng, Ikuyo Yamaguchi, Scott M Williams, James Gainer, Nancy J Brown, Debra Hazen-Martin, Lee-Jun C Wong, Jean E Robillard, Robert M Carey, Gilbert M Eisner, Pedro A Jose.   

Abstract

Essential hypertension has a heritability as high as 30-50%, but its genetic cause(s) has not been determined despite intensive investigation. The renal dopaminergic system exerts a pivotal role in maintaining fluid and electrolyte balance and participates in the pathogenesis of genetic hypertension. In genetic hypertension, the ability of dopamine and D(1)-like agonists to increase urinary sodium excretion is impaired. A defective coupling between the D(1) dopamine receptor and the G protein/effector enzyme complex in the proximal tubule of the kidney is the cause of the impaired renal dopaminergic action in genetic rodent and human essential hypertension. We now report that, in human essential hypertension, single nucleotide polymorphisms of a G protein-coupled receptor kinase, GRK4gamma, increase G protein-coupled receptor kinase (GRK) activity and cause the serine phosphorylation and uncoupling of the D(1) receptor from its G protein/effector enzyme complex in the renal proximal tubule and in transfected Chinese hamster ovary cells. Moreover, expressing GRK4gammaA142V but not the wild-type gene in transgenic mice produces hypertension and impairs the diuretic and natriuretic but not the hypotensive effects of D(1)-like agonist stimulation. These findings provide a mechanism for the D(1) receptor coupling defect in the kidney and may explain the inability of the kidney to properly excrete sodium in genetic hypertension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904438      PMCID: PMC122616          DOI: 10.1073/pnas.062694599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

Review 2.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

3.  D(1) dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats.

Authors:  X X Li; J Xu; S Zheng; F E Albrecht; J E Robillard; G M Eisner; P A Jose
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-06       Impact factor: 3.619

4.  Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status.

Authors:  D P O'Connell; N V Ragsdale; D G Boyd; R A Felder; R M Carey
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

5.  Palmitoylation of the luteinizing hormone/human chorionic gonadotropin receptor regulates receptor interaction with the arrestin-mediated internalization pathway.

Authors:  U M Munshi; H Peegel; K M Menon
Journal:  Eur J Biochem       Date:  2001-03

6.  Combinations of variations in multiple genes are associated with hypertension.

Authors:  S M Williams; J H Addy; J A Phillips; M Dai; J Kpodonu; J Afful; H Jackson; K Joseph; F Eason; M M Murray; P Epperson; A Aduonum; L J Wong; P A Jose; R A Felder
Journal:  Hypertension       Date:  2000-07       Impact factor: 10.190

7.  Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants.

Authors:  R T Premont; A D Macrae; R H Stoffel; N Chung; J A Pitcher; C Ambrose; J Inglese; M E MacDonald; R J Lefkowitz
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

8.  G protein-coupled receptor kinase-mediated desensitization of metabotropic glutamate receptor 1A protects against cell death.

Authors:  L B Dale; M Bhattacharya; P H Anborgh; B Murdoch; M Bhatia; S Nakanishi; S S Ferguson
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

9.  Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension.

Authors:  F E Albrecht; J Drago; R A Felder; M P Printz; G M Eisner; J E Robillard; D R Sibley; H J Westphal; P A Jose
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

10.  The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1.

Authors:  M Sallese; L Salvatore; E D'Urbano; G Sala; M Storto; T Launey; F Nicoletti; T Knöpfel; A De Blasi
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

View more
  96 in total

Review 1.  Potential dopamine-1 receptor stimulation in hypertension management.

Authors:  Mohammad Asghar; Seyed K Tayebati; Mustafa F Lokhandwala; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

Review 2.  Dopamine, the kidney, and hypertension.

Authors:  Raymond C Harris; Ming-Zhi Zhang
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 3.  Proximal tubular function and salt sensitivity.

Authors:  Michel Burnier; Murielle Bochud; Marc Maillard
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

4.  Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats.

Authors:  John J Gildea; Brandon A Kemp; Nancy L Howell; Robert E Van Sciver; Robert M Carey; Robin A Felder
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

5.  Sorting nexin 1 loss results in increased oxidative stress and hypertension.

Authors:  Jian Yang; Laureano D Asico; Amber L Beitelshees; Jun B Feranil; Xiaoyan Wang; John E Jones; Ines Armando; Santiago G Cuevas; Gary L Schwartz; John G Gums; Arlene B Chapman; Stephen T Turner; Eric Boerwinkle; Rhonda M Cooper-DeHoff; Julie A Johnson; Robin A Felder; Edward J Weinman; Chunyu Zeng; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-15       Impact factor: 5.191

Review 6.  Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance.

Authors:  John J Gildea
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

Review 7.  Renal dopamine and angiotensin II receptor signaling in age-related hypertension.

Authors:  Gaurav Chugh; Indira Pokkunuri; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-24

8.  Role of GRK4 in the regulation of arterial AT1 receptor in hypertension.

Authors:  Ken Chen; Chunjiang Fu; Caiyu Chen; Li Liu; Hongmei Ren; Yu Han; Jian Yang; Duofen He; Lin Zhou; Zhiwei Yang; Lianfeng Zhang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2013-11-11       Impact factor: 10.190

9.  Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats.

Authors:  Junichi Yatabe; Hironobu Sanada; Sanae Midorikawa; Shigeatsu Hashimoto; Tsuyoshi Watanabe; Peter M Andrews; Ines Armando; Xiaoyan Wang; Robin A Felder; Pedro A Jose
Journal:  Hypertens Res       Date:  2008-07       Impact factor: 3.872

10.  A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.

Authors:  John J Gildea; Dylan T Lahiff; Robert E Van Sciver; Ryan S Weiss; Neema Shah; Helen E McGrath; Cynthia D Schoeffel; Pedro A Jose; Robert M Carey; Robin A Felder
Journal:  Clin Chim Acta       Date:  2013-02-27       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.